OR WAIT null SECS
September 27, 2017
The FDA commissioner made a statement about the agency’s efforts to ensure patient access to safe compounded medicines.
August 25, 2017
Ajinomoto Althea’s Optima VFVM 7000 aseptic fill/finish line supports a range of drug substance APIs.
August 18, 2017
FDA sent a warning letter to Maple Rose Enterprises, Inc., dba Pencol Compounding Pharmacy, citing the company for violations of sterile manufacturing practices.
July 25, 2017
FDA sent a warning letter to Sage Products, Inc. regarding CGMP failures involving test methods, sampling, and sterilization procedures.
July 18, 2017
The agency cited the Italian company for aseptic processing failures.
July 02, 2017
Oral solid-dosage and parenteral drug manufacturing equipment and systems have made great strides in safety and efficiency.
Pharma company consolidation and outsourcing led to a de-emphasis of manufacturing and reduced investment in new technologies and facilities.
Advancements in cell culture and protein technology have opened the door for new therapies.
June 26, 2017
Fagron Sterile Services has voluntarily recalled three lots of Succinylcholine Chloride 20mg/mL 5mL syringe to the hospital/clinic level.
June 21, 2017
The need for flexibility and higher quality are driving advances in parenteral manufacturing and fill/finish equipment.